Drug Marketing Dilemma

Anthony discusses the imbalance between drug marketing and research funding, questioning the priorities in the pharmaceutical industry. Scott reflects on the impact of excessive marketing on drug quality and accessibility, highlighting the need for a shift in focus towards product improvement over promotion.